[ Price : $8.95]
FDA removes a Spero Therapeutics clinical hold on a Phase 2 trial of SPR720, an investigational oral product being developed for n...[ Price : $8.95]
FDA says it has temporarily postponed all face-to-face domestic and foreign inspectional work except for mission-critical inspecti...[ Price : $8.95]
FDA releases an FDA-483 with seven observations from an inspection at Union, NJ-based Ideal Pharmacy.[ Price : $8.95]
Federal Register notice: FDA announces that its Office of the Chief Scientist has modified its organizational structure.[ Price : $8.95]
The CDER Office of Pharmaceutical Quality issues a MAPP for its product quality assessors on consistent assessment of excess volum...[ Price : $8.95]
Columbia University College of Physicians and Surgeons psychiatry chair Jeffrey Lieberman makes the case for Robert Califf to retu...[ Price : $8.95]
FDAer Brooke Higgins discusses aseptic processing issues at a PDA/FDA joint regulatory conference.[ Price : $8.95]
FDA accepts for review a Samsung Bioepis sBLA for a high-concentration Humira biosimilar.